retatrutide weight loss clinical data just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a phase 2 study: • Up to 24.2% mean at 48 weeks Weight-loss medicine continues to evolve.

Why it matters: GLP-1s have been incredibly popularand theyre reshaping consumer spending habits

It is important to clarify that while weight loss is a common and beneficial side effect of Ozempic, it is not FDA-approved specifically for weight loss

It is important to note that use of medications such as beta blockers is contraindicated in these patients because they may result in syncope and increase the risk of death

Notwithstanding the impressive results that have been published to date, there is still a requirement for successful human trials to be completed prior to clinical translation

CVOTs primarily proved cardiovascular safety and tolerability of different GLP-1 receptor agonists, but also showed cardiovascular benefit of specific drugs

Gabriel Chiu and the team at Beverly Hills Plastic Surgery in Beverly Hills, CA, can review your medication use, weight loss progress, anesthesia considerations, and cosmetic goals during a single, personalized consultation